Nerve growth factor (NGF)-TrkA axis in head and neck squamous cell carcinoma triggers EMT and confers resistance to the EGFR inhibitor erlotinib

Details 詳細情報について

• CRID

  1360017286291133312

• DOI

  10.1016/j.canlet.2019.12.015

• ISSN

  03043835

• Web Site

  https://api.elsevier.com/content/article/PII:S0304383519306214?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0304383519306214?httpAccept=text/plain

• Data Source

  • Crossref